isoleucine has been researched along with Myeloproliferative Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chantepie, S; Damaj, G; Decamp, M; Henry, A; Hueso, T; Johnson-Ansah, H; Maitre, E; Mensi, S; Vilque, JP | 1 |
Atkinson, D; Bienz, N; Burns, A; Chowdhury, O; Clifford, R; Constantinescu, SN; Cross, N; Dusa, A; Gale, RE; Henderson, S; Jacobsen, SE; Mead, AJ; Moule, S; Pecquet, C; Rugless, M; Schuh, A; Score, J; Vyas, P; Woll, P | 1 |
2 other study(ies) available for isoleucine and Myeloproliferative Disorders
Article | Year |
---|---|
Successful Imatinib therapy as a bridge to transplant in an atypical myeloproliferative neoplasm.
Topics: Amino Acid Substitution; Combined Modality Therapy; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Isoleucine; Male; Middle Aged; Mutation, Missense; Myeloproliferative Disorders; Neoadjuvant Therapy; Receptors, Colony-Stimulating Factor; Threonine; Transplantation, Homologous; Treatment Outcome | 2019 |
Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
Topics: Adult; Amino Acid Substitution; Animals; Cells, Cultured; Family; Female; Germ-Line Mutation; Hematopoiesis; Humans; Isoleucine; Janus Kinase 2; Male; Mice; Mice, Inbred NOD; Mice, Transgenic; Middle Aged; Myeloproliferative Disorders; Valine | 2013 |